# Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

> **NCT00115518** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 30 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00115518
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2009-06
- **Final completion:** 2010-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115518, "Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00115518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*